Proteome Sciences PLC (PRM) - Total Assets

Latest as of June 2025: GBX8.35 Million GBX ≈ $1.02K USD

Based on the latest financial reports, Proteome Sciences PLC (PRM) holds total assets worth GBX8.35 Million GBX (≈ $1.02K USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of Proteome Sciences PLC for net asset value and shareholders' equity analysis.

Proteome Sciences PLC - Total Assets Trend (1994–2024)

This chart illustrates how Proteome Sciences PLC's total assets have evolved over time, based on quarterly financial data.

Proteome Sciences PLC - Asset Composition Analysis

Current Asset Composition (December 2024)

Proteome Sciences PLC's total assets of GBX8.35 Million consist of 28.1% current assets and 71.9% non-current assets.

Asset Category	Amount (GBX)	% of Total Assets
Cash & Equivalents	GBX0.00	12.3%
Accounts Receivable	GBX509.00K	5.5%
Inventory	GBX732.00K	8.0%
Property, Plant & Equipment	GBX0.00	0.0%
Intangible Assets	GBX0.00	0.0%
Goodwill	GBX4.22 Million	45.8%

Asset Composition Trend (1994–2024)

This chart illustrates how Proteome Sciences PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see PRM market cap.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Proteome Sciences PLC's current assets represent 28.1% of total assets in 2024, a decrease from 87.6% in 1994.
Cash Position: Cash and equivalents constituted 12.3% of total assets in 2024, down from 84.5% in 1994.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 45.0% of total assets, an increase from 0.0% in 1994.
Asset Diversification: The largest asset category is goodwill at 45.8% of total assets.

Proteome Sciences PLC Competitors by Total Assets

Key competitors of Proteome Sciences PLC based on total assets are shown below.

Company	Country	Total Assets
Sonic Healthcare Ltd AU:SHL	Australia	AU$17.03 Billion
Eurofins-Cerep SA PA:ALECR	France	€84.58 Million
Inoviq Ltd AU:IIQ	Australia	AU$24.52 Million
Bcal Diagnostics Ltd AU:BDX	Australia	AU$7.17 Million
Imagion Biosystems Ltd AU:IBX	Australia	AU$932.48K
Integral Diagnostics Ltd AU:IDX	Australia	AU$1.43 Billion
Australian Clinical Labs Ltd AU:ACL	Australia	AU$562.50 Million
Monash Ivf Group Ltd AU:MVF	Australia	AU$510.21 Million

Proteome Sciences PLC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	0.11	0.20	0.27
Quick Ratio	0.08	0.14	0.19
Cash Ratio	0.00	0.00	0.00
Working Capital	GBX-13.93 Million	GBX-10.62 Million	GBX-8.47 Million

Proteome Sciences PLC - Advanced Valuation Insights

This section examines the relationship between Proteome Sciences PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	-
Latest Market Cap to Assets Ratio	0.01
Asset Growth Rate (YoY)	-19.6%
Total Assets	GBX9.21 Million
Market Capitalization	$71.69K USD

Valuation Analysis

Below Book Valuation: The market values Proteome Sciences PLC's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Proteome Sciences PLC's assets decreased by 19.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Proteome Sciences PLC (1994–2024)

The table below shows the annual total assets of Proteome Sciences PLC from 1994 to 2024.

Year	Total Assets	Change
2024-12-31	GBX9.21 Million ≈ $1.12K	-19.65%
2023-12-31	GBX11.46 Million ≈ $1.39K	-100.00%
2022-12-31	GBX1.51 Trillion ≈ $184.17 Million	+9.35%
2021-12-31	GBX1.38 Trillion ≈ $168.43 Million	+2.58%
2020-12-31	GBX1.35 Trillion ≈ $164.20 Million	+18.35%
2019-12-31	GBX1.14 Trillion ≈ $138.73 Million	+0.61%
2018-12-31	GBX1.13 Trillion ≈ $137.89 Million	+0.00%
2017-12-31	GBX1.13 Trillion ≈ $137.88 Million	-6.58%
2016-12-31	GBX1.21 Trillion ≈ $147.60 Million	+8.31%
2015-12-31	GBX1.12 Trillion ≈ $136.27 Million	-17.52%
2014-12-31	GBX1.36 Trillion ≈ $165.22 Million	+1.06%
2013-12-31	GBX1.34 Trillion ≈ $163.48 Million	+19332952.37%
2012-12-31	GBX6.95 Million ≈ $845.60	-36.29%
2011-12-31	GBX10.91 Million ≈ $1.33K	-30.06%
2010-12-31	GBX15.60 Million ≈ $1.90K	+151.56%
2009-12-31	GBX6.20 Million ≈ $754.36	-3.76%
2008-12-31	GBX6.44 Million ≈ $783.81	-2.88%
2007-12-31	GBX6.63 Million ≈ $807.04	+3.71%
2006-12-31	GBX6.40 Million ≈ $778.21	-33.20%
2005-12-31	GBX9.57 Million ≈ $1.17K	-7.42%
2004-12-31	GBX10.34 Million ≈ $1.26K	-28.31%
2003-12-31	GBX14.43 Million ≈ $1.76K	+4.35%
2002-12-31	GBX13.83 Million ≈ $1.68K	+268.96%
2001-12-31	GBX3.75 Million ≈ $455.90	-11.10%
2000-12-31	GBX4.21 Million ≈ $512.84	+425.56%
1999-12-31	GBX802.00K ≈ $97.58	-57.63%
1998-12-31	GBX1.89 Million ≈ $230.32	-44.63%
1997-12-31	GBX3.42 Million ≈ $415.99	+464.19%
1996-12-31	GBX606.00K ≈ $73.73	-66.90%
1995-12-31	GBX1.83 Million ≈ $222.78	+338.04%
1994-12-31	GBX418.00K ≈ $50.86	0.00%
1994-10-31	GBX418.00K ≈ $50.86	--

About Proteome Sciences PLC

LSE:PRM UK Diagnostics & Research

Market Cap

$71.69K

GBX589.22 Million GBX

Market Cap Rank

#31054 Global

#1151 in UK

Share Price

GBX1.68

Change (1 day)

+12.00%

52-Week Range

GBX1.28 - GBX4.05

All Time High

GBX22.25